Jinbo Yang

Title: Jinbo Yang: Innovator in Anti-Tumor Drug Development

Introduction

Jinbo Yang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. With a total of 2 patents, his work focuses on innovative approaches to cancer treatment.

Latest Patents

One of Jinbo Yang's latest patents involves the use of Tegaserod in the preparation of an anti-tumor drug. This patent discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator. The findings indicate that Tegaserod exhibits excellent inhibitory effects on the growth of various tumor cells both in vivo and in vitro, making it a promising candidate for cancer treatment. Another significant patent pertains to the application of glucan in drug preparation. This patent describes the use of a β-1,3/1,6-glucan for creating a pharmaceutical composition that enhances the antitumor effects of immunotherapy, radiotherapy, or chemotherapy. It is particularly useful for treating conditions like leukopenia and thrombocytopenia.

Career Highlights

Jinbo Yang has worked with reputable organizations, including the Marine Biomedical Research Institute of Qingdao and Qingdao Conson Pharmaceutical Co., Ltd. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Jinbo Yang has collaborated with notable colleagues such as Qiaoling Song and Lijuan Wu. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Jinbo Yang stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of anti-tumor drug development. His innovative patents and collaborations reflect his commitment to advancing cancer treatment options.